Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Funk

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
The Journal of Biological Chemistry|March 30, 2001
The chromatin structure of the dual c-myc promoter P1/P2 is regulated by separate elementsT Albert, J Wells, J O Funk, et al.
Biomacromolecules|July 9, 2002
Protein micelles from lipoxygenase 3Pierre-Alexandre Brault, Muhammed S T Kariapper, Chau V Pham, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 25, 2000
Cutting edge: resistance to apoptosis and continuous proliferation of dendritic cells deficient for TNF receptor-1J O Funk, H Walczak, C Voigtländer, et al.
Cancer|October 24, 2000
Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphomaL M Heinzerling, M Urbanek, J O Funk, et al.
British Journal of Clinical Pharmacology|June 22, 2017
A phase I trial of PRN1008, a novel reversible covalent inhibitor of Bruton's tyrosine kinase, in healthy volunteersPatrick F Smith, Janakan Krishnarajah, Philip A Nunn, et al.
The Journal of Investigative Dermatology|July 10, 2001
Interleukin-6-resistant melanoma cells exhibit reduced activation of STAT3 and lack of inhibition of cyclin E-associated kinase activityM Böhm, U Schulte, J O Funk, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
The Journal of Biological Chemistry|March 30, 2001
The chromatin structure of the dual c-myc promoter P1/P2 is regulated by separate elementsT Albert, J Wells, J O Funk, et al.
Biomacromolecules|July 9, 2002
Protein micelles from lipoxygenase 3Pierre-Alexandre Brault, Muhammed S T Kariapper, Chau V Pham, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 25, 2000
Cutting edge: resistance to apoptosis and continuous proliferation of dendritic cells deficient for TNF receptor-1J O Funk, H Walczak, C Voigtländer, et al.
Cancer|October 24, 2000
Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphomaL M Heinzerling, M Urbanek, J O Funk, et al.
British Journal of Clinical Pharmacology|June 22, 2017
A phase I trial of PRN1008, a novel reversible covalent inhibitor of Bruton's tyrosine kinase, in healthy volunteersPatrick F Smith, Janakan Krishnarajah, Philip A Nunn, et al.
The Journal of Investigative Dermatology|July 10, 2001
Interleukin-6-resistant melanoma cells exhibit reduced activation of STAT3 and lack of inhibition of cyclin E-associated kinase activityM Böhm, U Schulte, J O Funk, et al.
Pageof 8